{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Largo",
      "state": "FL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "89395",
      "recalling_firm": "VistaPharm, Inc.",
      "address_1": "7265 Ulmerton Rd",
      "address_2": "N/A",
      "postal_code": "33771-4809",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within the United States including Puerto Rico",
      "recall_number": "D-0376-2022",
      "product_description": "Clobazam Oral Suspension 2.5 mg/mL, 120 mL bottles, Rx only,  Manufactured by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-058-04",
      "product_quantity": "18,456 bottles",
      "reason_for_recall": "Failed Stability Specifications",
      "recall_initiation_date": "20220107",
      "center_classification_date": "20220118",
      "termination_date": "20241213",
      "report_date": "20220126",
      "code_info": "Lots #: 678900, 682000, 682400, Exp. 5/31/2022; 680600, 680800, 681000 Exp. 5/30/2022; 683200, 685200 Exp. 6/30/2022; 728900, 733100 Exp. Date 12/31/2022; 738600 Exp. 1/31/2023; 740600, 741600 Exp. 2/28/2023; 749800, 750900, 752400 Exp. 3/31/2023; 775700 Exp. 6/30/2023"
    }
  ]
}